Read + Share
Amedeo Smart
Independent Medical Education
Parisi R, Cowen EA, Stoll JR, Zhu H, et al. Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia. Leuk Res 2022;123:106970.PMID: 36308802
Email
LinkedIn
Facebook
Twitter
Privacy Policy